Your browser doesn't support javascript.
loading
Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529
Qian Wang; Saumya Anang; Sho Iketani; Yicheng Guo; Lihong Liu; David D Ho; Joseph G Sodroski.
Affiliation
  • Qian Wang; Dana-Farber Cancer Institute
  • Saumya Anang; Dana-Farber Cancer Institute
  • Sho Iketani; Columbia University Irving Medical Center
  • Yicheng Guo; Columbia University Irving Medical Center
  • Lihong Liu; Columbia University Irving Medical Center
  • David D Ho; Columbia University Irving Medical Center
  • Joseph G Sodroski; Dana-Farber Cancer Institute
Preprint in English | bioRxiv | ID: ppbiorxiv-474288
ABSTRACT
The recently emerged B.1.1.529 (Omicron) SARS-CoV-2 variant has a highly divergent spike (S) glycoprotein. We compared the functional properties of B.1.1.529 S with those of previous globally prevalent SARS-CoV-2 variants, D614G and B.1.617.2. Relative to these variants, B.1.1.529 S exhibits decreased processing, resulting in less efficient syncytium formation and lower S incorporation into virus particles. Nonetheless, B.1.1.529 S supports virus infection equivalently. B.1.1.529 and B.1.617.2 S glycoproteins bind ACE2 with higher affinity than D614G S. The unliganded B.1.1.529 S trimer is less stable at low temperatures than the other SARS-CoV-2 spikes, a property related to spike conformation. Upon ACE2 binding, the B.1.1.529 S trimer sheds S1 at 37 degrees but not at 0 degrees C. B.1.1.529 pseudoviruses are relatively resistant to neutralization by sera from convalescent COVID-19 patients and vaccinees. These properties of the B.1.1.529 spike glycoprotein likely influence the transmission, cytopathic effects and immune evasion of this emerging variant.
License
cc_no
Full text: Available Collection: Preprints Database: bioRxiv Language: English Year: 2021 Document type: Preprint
Full text: Available Collection: Preprints Database: bioRxiv Language: English Year: 2021 Document type: Preprint
...